nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—UGT2B7—Ezetimibe—atherosclerosis	0.184	0.282	CbGbCtD
Epirubicin—UGT2B7—Simvastatin—atherosclerosis	0.171	0.262	CbGbCtD
Epirubicin—UGT2B7—Lovastatin—atherosclerosis	0.167	0.256	CbGbCtD
Epirubicin—ABCC1—Rosuvastatin—atherosclerosis	0.13	0.2	CbGbCtD
Epirubicin—CHD1—Pitavastatin—Rosuvastatin—atherosclerosis	0.00244	0.381	CbGdCrCtD
Epirubicin—Doxorubicin—NOS3—atherosclerosis	0.00148	0.509	CrCbGaD
Epirubicin—Doxorubicin—NOS2—atherosclerosis	0.00143	0.491	CrCbGaD
Epirubicin—CHD1—adipose tissue—atherosclerosis	0.00111	0.113	CbGeAlD
Epirubicin—AURKA—Fluvastatin—Rosuvastatin—atherosclerosis	0.000984	0.154	CbGdCrCtD
Epirubicin—AURKA—Simvastatin—Pravastatin—atherosclerosis	0.000941	0.147	CbGdCrCtD
Epirubicin—AURKA—Simvastatin—Lovastatin—atherosclerosis	0.000941	0.147	CbGdCrCtD
Epirubicin—YWHAG—connective tissue—atherosclerosis	0.000896	0.0912	CbGeAlD
Epirubicin—YWHAG—cardiovascular system—atherosclerosis	0.000779	0.0794	CbGeAlD
Epirubicin—CHD1—liver—atherosclerosis	0.000779	0.0793	CbGeAlD
Epirubicin—DHCR7—adipose tissue—atherosclerosis	0.000749	0.0763	CbGeAlD
Epirubicin—YWHAG—adipose tissue—atherosclerosis	0.000687	0.07	CbGeAlD
Epirubicin—PLA2G4A—connective tissue—atherosclerosis	0.000668	0.068	CbGeAlD
Epirubicin—AURKA—liver—atherosclerosis	0.000628	0.0639	CbGeAlD
Epirubicin—PLA2G4A—cardiovascular system—atherosclerosis	0.000581	0.0592	CbGeAlD
Epirubicin—DHCR7—liver—atherosclerosis	0.000525	0.0535	CbGeAlD
Epirubicin—PLA2G4A—adipose tissue—atherosclerosis	0.000513	0.0522	CbGeAlD
Epirubicin—TOP2A—adipose tissue—atherosclerosis	0.000487	0.0496	CbGeAlD
Epirubicin—YWHAG—liver—atherosclerosis	0.000482	0.0491	CbGeAlD
Epirubicin—UGT2B7—liver—atherosclerosis	0.000435	0.0443	CbGeAlD
Epirubicin—TOP2A—Fluvastatin—Rosuvastatin—atherosclerosis	0.000376	0.0587	CbGdCrCtD
Epirubicin—TOP2A—Simvastatin—Pravastatin—atherosclerosis	0.000359	0.0562	CbGdCrCtD
Epirubicin—TOP2A—Simvastatin—Lovastatin—atherosclerosis	0.000359	0.0562	CbGdCrCtD
Epirubicin—ABCC1—adipose tissue—atherosclerosis	0.000293	0.0299	CbGeAlD
Epirubicin—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000287	0.00143	CcSEcCtD
Epirubicin—Anaemia—Ezetimibe—atherosclerosis	0.000286	0.00143	CcSEcCtD
Epirubicin—Tinnitus—Pravastatin—atherosclerosis	0.000285	0.00143	CcSEcCtD
Epirubicin—Malaise—Lovastatin—atherosclerosis	0.000284	0.00142	CcSEcCtD
Epirubicin—Cardiac disorder—Pravastatin—atherosclerosis	0.000284	0.00142	CcSEcCtD
Epirubicin—Flushing—Pravastatin—atherosclerosis	0.000284	0.00142	CcSEcCtD
Epirubicin—Muscle spasms—Simvastatin—atherosclerosis	0.000283	0.00142	CcSEcCtD
Epirubicin—Vertigo—Lovastatin—atherosclerosis	0.000283	0.00142	CcSEcCtD
Epirubicin—Angiopathy—Niacin—atherosclerosis	0.000282	0.00141	CcSEcCtD
Epirubicin—Leukopenia—Lovastatin—atherosclerosis	0.000282	0.00141	CcSEcCtD
Epirubicin—Chills—Niacin—atherosclerosis	0.000279	0.0014	CcSEcCtD
Epirubicin—Malaise—Ezetimibe—atherosclerosis	0.000279	0.00139	CcSEcCtD
Epirubicin—Vision blurred—Simvastatin—atherosclerosis	0.000278	0.00139	CcSEcCtD
Epirubicin—Arrhythmia—Niacin—atherosclerosis	0.000278	0.00139	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000276	0.00138	CcSEcCtD
Epirubicin—Alopecia—Niacin—atherosclerosis	0.000275	0.00137	CcSEcCtD
Epirubicin—Chills—Pravastatin—atherosclerosis	0.000275	0.00137	CcSEcCtD
Epirubicin—Insomnia—Rosuvastatin—atherosclerosis	0.000274	0.00137	CcSEcCtD
Epirubicin—Ill-defined disorder—Simvastatin—atherosclerosis	0.000273	0.00137	CcSEcCtD
Epirubicin—Arrhythmia—Pravastatin—atherosclerosis	0.000273	0.00137	CcSEcCtD
Epirubicin—Palpitations—Ezetimibe—atherosclerosis	0.000273	0.00137	CcSEcCtD
Epirubicin—Paraesthesia—Rosuvastatin—atherosclerosis	0.000272	0.00136	CcSEcCtD
Epirubicin—Anaemia—Simvastatin—atherosclerosis	0.000272	0.00136	CcSEcCtD
Epirubicin—Erythema—Niacin—atherosclerosis	0.00027	0.00135	CcSEcCtD
Epirubicin—Malnutrition—Niacin—atherosclerosis	0.00027	0.00135	CcSEcCtD
Epirubicin—Alopecia—Pravastatin—atherosclerosis	0.00027	0.00135	CcSEcCtD
Epirubicin—Cough—Ezetimibe—atherosclerosis	0.00027	0.00135	CcSEcCtD
Epirubicin—Myalgia—Lovastatin—atherosclerosis	0.000268	0.00134	CcSEcCtD
Epirubicin—Chest pain—Lovastatin—atherosclerosis	0.000268	0.00134	CcSEcCtD
Epirubicin—Arthralgia—Lovastatin—atherosclerosis	0.000268	0.00134	CcSEcCtD
Epirubicin—Anxiety—Lovastatin—atherosclerosis	0.000267	0.00134	CcSEcCtD
Epirubicin—Dyspepsia—Rosuvastatin—atherosclerosis	0.000267	0.00134	CcSEcCtD
Epirubicin—Hypertension—Ezetimibe—atherosclerosis	0.000267	0.00133	CcSEcCtD
Epirubicin—Flatulence—Niacin—atherosclerosis	0.000267	0.00133	CcSEcCtD
Epirubicin—Malaise—Simvastatin—atherosclerosis	0.000266	0.00133	CcSEcCtD
Epirubicin—Tension—Niacin—atherosclerosis	0.000265	0.00133	CcSEcCtD
Epirubicin—Discomfort—Lovastatin—atherosclerosis	0.000265	0.00133	CcSEcCtD
Epirubicin—Vertigo—Simvastatin—atherosclerosis	0.000265	0.00132	CcSEcCtD
Epirubicin—Leukopenia—Simvastatin—atherosclerosis	0.000264	0.00132	CcSEcCtD
Epirubicin—Myalgia—Ezetimibe—atherosclerosis	0.000263	0.00132	CcSEcCtD
Epirubicin—Arthralgia—Ezetimibe—atherosclerosis	0.000263	0.00132	CcSEcCtD
Epirubicin—Chest pain—Ezetimibe—atherosclerosis	0.000263	0.00132	CcSEcCtD
Epirubicin—Nervousness—Niacin—atherosclerosis	0.000263	0.00131	CcSEcCtD
Epirubicin—Flatulence—Pravastatin—atherosclerosis	0.000262	0.00131	CcSEcCtD
Epirubicin—Dry mouth—Lovastatin—atherosclerosis	0.000262	0.00131	CcSEcCtD
Epirubicin—Tension—Pravastatin—atherosclerosis	0.000261	0.00131	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000261	0.00131	CcSEcCtD
Epirubicin—Dysgeusia—Pravastatin—atherosclerosis	0.000261	0.00131	CcSEcCtD
Epirubicin—Muscle spasms—Niacin—atherosclerosis	0.00026	0.0013	CcSEcCtD
Epirubicin—Discomfort—Ezetimibe—atherosclerosis	0.00026	0.0013	CcSEcCtD
Epirubicin—Constipation—Rosuvastatin—atherosclerosis	0.000259	0.0013	CcSEcCtD
Epirubicin—Pain—Rosuvastatin—atherosclerosis	0.000259	0.0013	CcSEcCtD
Epirubicin—Confusional state—Lovastatin—atherosclerosis	0.000259	0.0013	CcSEcCtD
Epirubicin—Nervousness—Pravastatin—atherosclerosis	0.000259	0.00129	CcSEcCtD
Epirubicin—Dry mouth—Ezetimibe—atherosclerosis	0.000257	0.00129	CcSEcCtD
Epirubicin—Anaphylactic shock—Lovastatin—atherosclerosis	0.000257	0.00129	CcSEcCtD
Epirubicin—Muscle spasms—Pravastatin—atherosclerosis	0.000256	0.00128	CcSEcCtD
Epirubicin—Infection—Lovastatin—atherosclerosis	0.000255	0.00128	CcSEcCtD
Epirubicin—Vision blurred—Niacin—atherosclerosis	0.000255	0.00128	CcSEcCtD
Epirubicin—Confusional state—Ezetimibe—atherosclerosis	0.000254	0.00127	CcSEcCtD
Epirubicin—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000252	0.00126	CcSEcCtD
Epirubicin—Thrombocytopenia—Lovastatin—atherosclerosis	0.000252	0.00126	CcSEcCtD
Epirubicin—Vision blurred—Pravastatin—atherosclerosis	0.000251	0.00126	CcSEcCtD
Epirubicin—Arthralgia—Simvastatin—atherosclerosis	0.000251	0.00125	CcSEcCtD
Epirubicin—Chest pain—Simvastatin—atherosclerosis	0.000251	0.00125	CcSEcCtD
Epirubicin—Myalgia—Simvastatin—atherosclerosis	0.000251	0.00125	CcSEcCtD
Epirubicin—Infection—Ezetimibe—atherosclerosis	0.00025	0.00125	CcSEcCtD
Epirubicin—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00025	0.00125	CcSEcCtD
Epirubicin—Anxiety—Simvastatin—atherosclerosis	0.00025	0.00125	CcSEcCtD
Epirubicin—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000248	0.00124	CcSEcCtD
Epirubicin—Discomfort—Simvastatin—atherosclerosis	0.000248	0.00124	CcSEcCtD
Epirubicin—Nervous system disorder—Ezetimibe—atherosclerosis	0.000247	0.00124	CcSEcCtD
Epirubicin—Ill-defined disorder—Pravastatin—atherosclerosis	0.000247	0.00124	CcSEcCtD
Epirubicin—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000247	0.00124	CcSEcCtD
Epirubicin—Anaemia—Pravastatin—atherosclerosis	0.000246	0.00123	CcSEcCtD
Epirubicin—Anorexia—Lovastatin—atherosclerosis	0.000245	0.00123	CcSEcCtD
Epirubicin—Skin disorder—Ezetimibe—atherosclerosis	0.000245	0.00123	CcSEcCtD
Epirubicin—Vertigo—Niacin—atherosclerosis	0.000243	0.00122	CcSEcCtD
Epirubicin—Syncope—Niacin—atherosclerosis	0.000243	0.00121	CcSEcCtD
Epirubicin—Confusional state—Simvastatin—atherosclerosis	0.000242	0.00121	CcSEcCtD
Epirubicin—Leukopenia—Niacin—atherosclerosis	0.000242	0.00121	CcSEcCtD
Epirubicin—Urticaria—Rosuvastatin—atherosclerosis	0.000241	0.00121	CcSEcCtD
Epirubicin—Anaphylactic shock—Simvastatin—atherosclerosis	0.00024	0.0012	CcSEcCtD
Epirubicin—Oedema—Simvastatin—atherosclerosis	0.00024	0.0012	CcSEcCtD
Epirubicin—Malaise—Pravastatin—atherosclerosis	0.00024	0.0012	CcSEcCtD
Epirubicin—Abdominal pain—Rosuvastatin—atherosclerosis	0.00024	0.0012	CcSEcCtD
Epirubicin—Vertigo—Pravastatin—atherosclerosis	0.000239	0.0012	CcSEcCtD
Epirubicin—Palpitations—Niacin—atherosclerosis	0.000239	0.0012	CcSEcCtD
Epirubicin—Infection—Simvastatin—atherosclerosis	0.000239	0.0012	CcSEcCtD
Epirubicin—Leukopenia—Pravastatin—atherosclerosis	0.000238	0.00119	CcSEcCtD
Epirubicin—Loss of consciousness—Niacin—atherosclerosis	0.000238	0.00119	CcSEcCtD
Epirubicin—Cough—Niacin—atherosclerosis	0.000236	0.00118	CcSEcCtD
Epirubicin—Thrombocytopenia—Simvastatin—atherosclerosis	0.000235	0.00118	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000234	0.00117	CcSEcCtD
Epirubicin—Insomnia—Lovastatin—atherosclerosis	0.000232	0.00116	CcSEcCtD
Epirubicin—Cough—Pravastatin—atherosclerosis	0.000232	0.00116	CcSEcCtD
Epirubicin—Paraesthesia—Lovastatin—atherosclerosis	0.000231	0.00115	CcSEcCtD
Epirubicin—Arthralgia—Niacin—atherosclerosis	0.00023	0.00115	CcSEcCtD
Epirubicin—Myalgia—Niacin—atherosclerosis	0.00023	0.00115	CcSEcCtD
Epirubicin—Hypertension—Pravastatin—atherosclerosis	0.00023	0.00115	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00023	0.00115	CcSEcCtD
Epirubicin—Anorexia—Simvastatin—atherosclerosis	0.000229	0.00115	CcSEcCtD
Epirubicin—Dyspnoea—Lovastatin—atherosclerosis	0.000229	0.00115	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000229	0.00114	CcSEcCtD
Epirubicin—Insomnia—Ezetimibe—atherosclerosis	0.000228	0.00114	CcSEcCtD
Epirubicin—Chest pain—Pravastatin—atherosclerosis	0.000227	0.00113	CcSEcCtD
Epirubicin—Arthralgia—Pravastatin—atherosclerosis	0.000227	0.00113	CcSEcCtD
Epirubicin—Myalgia—Pravastatin—atherosclerosis	0.000227	0.00113	CcSEcCtD
Epirubicin—Paraesthesia—Ezetimibe—atherosclerosis	0.000226	0.00113	CcSEcCtD
Epirubicin—Dyspepsia—Lovastatin—atherosclerosis	0.000226	0.00113	CcSEcCtD
Epirubicin—Anxiety—Pravastatin—atherosclerosis	0.000226	0.00113	CcSEcCtD
Epirubicin—Dry mouth—Niacin—atherosclerosis	0.000225	0.00113	CcSEcCtD
Epirubicin—Dyspnoea—Ezetimibe—atherosclerosis	0.000225	0.00112	CcSEcCtD
Epirubicin—Discomfort—Pravastatin—atherosclerosis	0.000224	0.00112	CcSEcCtD
Epirubicin—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000223	0.00112	CcSEcCtD
Epirubicin—Decreased appetite—Lovastatin—atherosclerosis	0.000223	0.00112	CcSEcCtD
Epirubicin—Dyspepsia—Ezetimibe—atherosclerosis	0.000222	0.00111	CcSEcCtD
Epirubicin—Fatigue—Lovastatin—atherosclerosis	0.000222	0.00111	CcSEcCtD
Epirubicin—Anaphylactic shock—Niacin—atherosclerosis	0.000221	0.0011	CcSEcCtD
Epirubicin—Oedema—Niacin—atherosclerosis	0.000221	0.0011	CcSEcCtD
Epirubicin—Pain—Lovastatin—atherosclerosis	0.00022	0.0011	CcSEcCtD
Epirubicin—Constipation—Lovastatin—atherosclerosis	0.00022	0.0011	CcSEcCtD
Epirubicin—Confusional state—Pravastatin—atherosclerosis	0.000219	0.0011	CcSEcCtD
Epirubicin—Decreased appetite—Ezetimibe—atherosclerosis	0.000219	0.0011	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000219	0.0011	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000218	0.00109	CcSEcCtD
Epirubicin—Asthenia—Rosuvastatin—atherosclerosis	0.000218	0.00109	CcSEcCtD
Epirubicin—Insomnia—Simvastatin—atherosclerosis	0.000217	0.00109	CcSEcCtD
Epirubicin—Anaphylactic shock—Pravastatin—atherosclerosis	0.000217	0.00109	CcSEcCtD
Epirubicin—Oedema—Pravastatin—atherosclerosis	0.000217	0.00109	CcSEcCtD
Epirubicin—Fatigue—Ezetimibe—atherosclerosis	0.000217	0.00109	CcSEcCtD
Epirubicin—Shock—Niacin—atherosclerosis	0.000217	0.00109	CcSEcCtD
Epirubicin—Infection—Pravastatin—atherosclerosis	0.000216	0.00108	CcSEcCtD
Epirubicin—Paraesthesia—Simvastatin—atherosclerosis	0.000216	0.00108	CcSEcCtD
Epirubicin—Pain—Ezetimibe—atherosclerosis	0.000216	0.00108	CcSEcCtD
Epirubicin—Constipation—Ezetimibe—atherosclerosis	0.000216	0.00108	CcSEcCtD
Epirubicin—Tachycardia—Niacin—atherosclerosis	0.000215	0.00108	CcSEcCtD
Epirubicin—Pruritus—Rosuvastatin—atherosclerosis	0.000215	0.00107	CcSEcCtD
Epirubicin—Skin disorder—Niacin—atherosclerosis	0.000214	0.00107	CcSEcCtD
Epirubicin—Dyspnoea—Simvastatin—atherosclerosis	0.000214	0.00107	CcSEcCtD
Epirubicin—Hyperhidrosis—Niacin—atherosclerosis	0.000213	0.00107	CcSEcCtD
Epirubicin—Thrombocytopenia—Pravastatin—atherosclerosis	0.000213	0.00106	CcSEcCtD
Epirubicin—Feeling abnormal—Lovastatin—atherosclerosis	0.000212	0.00106	CcSEcCtD
Epirubicin—Dyspepsia—Simvastatin—atherosclerosis	0.000212	0.00106	CcSEcCtD
Epirubicin—Anorexia—Niacin—atherosclerosis	0.00021	0.00105	CcSEcCtD
Epirubicin—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00021	0.00105	CcSEcCtD
Epirubicin—Hyperhidrosis—Pravastatin—atherosclerosis	0.00021	0.00105	CcSEcCtD
Epirubicin—Decreased appetite—Simvastatin—atherosclerosis	0.000209	0.00105	CcSEcCtD
Epirubicin—Feeling abnormal—Ezetimibe—atherosclerosis	0.000208	0.00104	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000208	0.00104	CcSEcCtD
Epirubicin—Diarrhoea—Rosuvastatin—atherosclerosis	0.000208	0.00104	CcSEcCtD
Epirubicin—Fatigue—Simvastatin—atherosclerosis	0.000207	0.00104	CcSEcCtD
Epirubicin—Anorexia—Pravastatin—atherosclerosis	0.000207	0.00104	CcSEcCtD
Epirubicin—Hypotension—Niacin—atherosclerosis	0.000206	0.00103	CcSEcCtD
Epirubicin—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000206	0.00103	CcSEcCtD
Epirubicin—ABCC1—liver—atherosclerosis	0.000206	0.0209	CbGeAlD
Epirubicin—Pain—Simvastatin—atherosclerosis	0.000206	0.00103	CcSEcCtD
Epirubicin—Constipation—Simvastatin—atherosclerosis	0.000206	0.00103	CcSEcCtD
Epirubicin—Urticaria—Lovastatin—atherosclerosis	0.000204	0.00102	CcSEcCtD
Epirubicin—Body temperature increased—Lovastatin—atherosclerosis	0.000203	0.00102	CcSEcCtD
Epirubicin—Abdominal pain—Lovastatin—atherosclerosis	0.000203	0.00102	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000201	0.00101	CcSEcCtD
Epirubicin—Dizziness—Rosuvastatin—atherosclerosis	0.000201	0.001	CcSEcCtD
Epirubicin—Urticaria—Ezetimibe—atherosclerosis	0.0002	0.001	CcSEcCtD
Epirubicin—Insomnia—Niacin—atherosclerosis	0.0002	0.000999	CcSEcCtD
Epirubicin—Abdominal pain—Ezetimibe—atherosclerosis	0.000199	0.000997	CcSEcCtD
Epirubicin—Body temperature increased—Ezetimibe—atherosclerosis	0.000199	0.000997	CcSEcCtD
Epirubicin—Paraesthesia—Niacin—atherosclerosis	0.000198	0.000992	CcSEcCtD
Epirubicin—Feeling abnormal—Simvastatin—atherosclerosis	0.000198	0.000991	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000198	0.000991	CcSEcCtD
Epirubicin—Dyspnoea—Niacin—atherosclerosis	0.000197	0.000985	CcSEcCtD
Epirubicin—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000197	0.000984	CcSEcCtD
Epirubicin—Insomnia—Pravastatin—atherosclerosis	0.000197	0.000984	CcSEcCtD
Epirubicin—Somnolence—Niacin—atherosclerosis	0.000196	0.000982	CcSEcCtD
Epirubicin—Paraesthesia—Pravastatin—atherosclerosis	0.000195	0.000977	CcSEcCtD
Epirubicin—Dyspepsia—Niacin—atherosclerosis	0.000194	0.000972	CcSEcCtD
Epirubicin—Dyspnoea—Pravastatin—atherosclerosis	0.000194	0.00097	CcSEcCtD
Epirubicin—Decreased appetite—Niacin—atherosclerosis	0.000192	0.00096	CcSEcCtD
Epirubicin—Dyspepsia—Pravastatin—atherosclerosis	0.000191	0.000957	CcSEcCtD
Epirubicin—Rash—Rosuvastatin—atherosclerosis	0.000191	0.000957	CcSEcCtD
Epirubicin—Dermatitis—Rosuvastatin—atherosclerosis	0.000191	0.000956	CcSEcCtD
Epirubicin—Urticaria—Simvastatin—atherosclerosis	0.000191	0.000956	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Niacin—atherosclerosis	0.000191	0.000954	CcSEcCtD
Epirubicin—Body temperature increased—Simvastatin—atherosclerosis	0.00019	0.000951	CcSEcCtD
Epirubicin—Abdominal pain—Simvastatin—atherosclerosis	0.00019	0.000951	CcSEcCtD
Epirubicin—Headache—Rosuvastatin—atherosclerosis	0.00019	0.000951	CcSEcCtD
Epirubicin—Hypersensitivity—Lovastatin—atherosclerosis	0.000189	0.000948	CcSEcCtD
Epirubicin—Decreased appetite—Pravastatin—atherosclerosis	0.000189	0.000946	CcSEcCtD
Epirubicin—Pain—Niacin—atherosclerosis	0.000189	0.000945	CcSEcCtD
Epirubicin—Fatigue—Pravastatin—atherosclerosis	0.000187	0.000938	CcSEcCtD
Epirubicin—Pain—Pravastatin—atherosclerosis	0.000186	0.00093	CcSEcCtD
Epirubicin—Constipation—Pravastatin—atherosclerosis	0.000186	0.00093	CcSEcCtD
Epirubicin—Hypersensitivity—Ezetimibe—atherosclerosis	0.000186	0.000929	CcSEcCtD
Epirubicin—Asthenia—Lovastatin—atherosclerosis	0.000184	0.000923	CcSEcCtD
Epirubicin—Pruritus—Lovastatin—atherosclerosis	0.000182	0.00091	CcSEcCtD
Epirubicin—Asthenia—Ezetimibe—atherosclerosis	0.000181	0.000905	CcSEcCtD
Epirubicin—Gastrointestinal pain—Niacin—atherosclerosis	0.000181	0.000903	CcSEcCtD
Epirubicin—Nausea—Rosuvastatin—atherosclerosis	0.00018	0.000902	CcSEcCtD
Epirubicin—Feeling abnormal—Pravastatin—atherosclerosis	0.000179	0.000896	CcSEcCtD
Epirubicin—Pruritus—Ezetimibe—atherosclerosis	0.000178	0.000893	CcSEcCtD
Epirubicin—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000178	0.000889	CcSEcCtD
Epirubicin—Hypersensitivity—Simvastatin—atherosclerosis	0.000177	0.000886	CcSEcCtD
Epirubicin—Diarrhoea—Lovastatin—atherosclerosis	0.000176	0.00088	CcSEcCtD
Epirubicin—Urticaria—Niacin—atherosclerosis	0.000175	0.000878	CcSEcCtD
Epirubicin—Abdominal pain—Niacin—atherosclerosis	0.000175	0.000873	CcSEcCtD
Epirubicin—Body temperature increased—Niacin—atherosclerosis	0.000175	0.000873	CcSEcCtD
Epirubicin—Urticaria—Pravastatin—atherosclerosis	0.000173	0.000864	CcSEcCtD
Epirubicin—Asthenia—Simvastatin—atherosclerosis	0.000172	0.000863	CcSEcCtD
Epirubicin—Diarrhoea—Ezetimibe—atherosclerosis	0.000172	0.000863	CcSEcCtD
Epirubicin—Abdominal pain—Pravastatin—atherosclerosis	0.000172	0.00086	CcSEcCtD
Epirubicin—Body temperature increased—Pravastatin—atherosclerosis	0.000172	0.00086	CcSEcCtD
Epirubicin—Pruritus—Simvastatin—atherosclerosis	0.00017	0.000851	CcSEcCtD
Epirubicin—Dizziness—Lovastatin—atherosclerosis	0.00017	0.000851	CcSEcCtD
Epirubicin—Dizziness—Ezetimibe—atherosclerosis	0.000167	0.000834	CcSEcCtD
Epirubicin—Diarrhoea—Simvastatin—atherosclerosis	0.000164	0.000823	CcSEcCtD
Epirubicin—Vomiting—Lovastatin—atherosclerosis	0.000163	0.000818	CcSEcCtD
Epirubicin—Hypersensitivity—Niacin—atherosclerosis	0.000163	0.000814	CcSEcCtD
Epirubicin—Rash—Lovastatin—atherosclerosis	0.000162	0.000811	CcSEcCtD
Epirubicin—Dermatitis—Lovastatin—atherosclerosis	0.000162	0.00081	CcSEcCtD
Epirubicin—Headache—Lovastatin—atherosclerosis	0.000161	0.000806	CcSEcCtD
Epirubicin—Vomiting—Ezetimibe—atherosclerosis	0.00016	0.000802	CcSEcCtD
Epirubicin—Hypersensitivity—Pravastatin—atherosclerosis	0.00016	0.000801	CcSEcCtD
Epirubicin—Dizziness—Simvastatin—atherosclerosis	0.000159	0.000796	CcSEcCtD
Epirubicin—Rash—Ezetimibe—atherosclerosis	0.000159	0.000795	CcSEcCtD
Epirubicin—Dermatitis—Ezetimibe—atherosclerosis	0.000159	0.000795	CcSEcCtD
Epirubicin—Asthenia—Niacin—atherosclerosis	0.000158	0.000793	CcSEcCtD
Epirubicin—Headache—Ezetimibe—atherosclerosis	0.000158	0.00079	CcSEcCtD
Epirubicin—Pruritus—Niacin—atherosclerosis	0.000156	0.000782	CcSEcCtD
Epirubicin—Asthenia—Pravastatin—atherosclerosis	0.000156	0.00078	CcSEcCtD
Epirubicin—Pruritus—Pravastatin—atherosclerosis	0.000154	0.00077	CcSEcCtD
Epirubicin—Vomiting—Simvastatin—atherosclerosis	0.000153	0.000765	CcSEcCtD
Epirubicin—Nausea—Lovastatin—atherosclerosis	0.000153	0.000764	CcSEcCtD
Epirubicin—Rash—Simvastatin—atherosclerosis	0.000152	0.000759	CcSEcCtD
Epirubicin—Dermatitis—Simvastatin—atherosclerosis	0.000151	0.000758	CcSEcCtD
Epirubicin—Diarrhoea—Niacin—atherosclerosis	0.000151	0.000756	CcSEcCtD
Epirubicin—Headache—Simvastatin—atherosclerosis	0.000151	0.000754	CcSEcCtD
Epirubicin—Nausea—Ezetimibe—atherosclerosis	0.00015	0.000749	CcSEcCtD
Epirubicin—Diarrhoea—Pravastatin—atherosclerosis	0.000149	0.000744	CcSEcCtD
Epirubicin—Dizziness—Niacin—atherosclerosis	0.000146	0.00073	CcSEcCtD
Epirubicin—Dizziness—Pravastatin—atherosclerosis	0.000144	0.000719	CcSEcCtD
Epirubicin—Nausea—Simvastatin—atherosclerosis	0.000143	0.000715	CcSEcCtD
Epirubicin—Vomiting—Niacin—atherosclerosis	0.00014	0.000702	CcSEcCtD
Epirubicin—Rash—Niacin—atherosclerosis	0.000139	0.000697	CcSEcCtD
Epirubicin—Dermatitis—Niacin—atherosclerosis	0.000139	0.000696	CcSEcCtD
Epirubicin—Headache—Niacin—atherosclerosis	0.000138	0.000692	CcSEcCtD
Epirubicin—Vomiting—Pravastatin—atherosclerosis	0.000138	0.000692	CcSEcCtD
Epirubicin—Rash—Pravastatin—atherosclerosis	0.000137	0.000686	CcSEcCtD
Epirubicin—Dermatitis—Pravastatin—atherosclerosis	0.000137	0.000685	CcSEcCtD
Epirubicin—Headache—Pravastatin—atherosclerosis	0.000136	0.000681	CcSEcCtD
Epirubicin—Nausea—Niacin—atherosclerosis	0.000131	0.000656	CcSEcCtD
Epirubicin—Nausea—Pravastatin—atherosclerosis	0.000129	0.000646	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—EDNRA—atherosclerosis	4.05e-05	0.000313	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—PLG—atherosclerosis	4.05e-05	0.000313	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—APOA5—atherosclerosis	4.04e-05	0.000312	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—APOA4—atherosclerosis	4.02e-05	0.000311	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—BGN—atherosclerosis	4e-05	0.000309	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	3.98e-05	0.000308	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	3.97e-05	0.000307	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—APOA5—atherosclerosis	3.96e-05	0.000306	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—GHRL—atherosclerosis	3.95e-05	0.000306	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP7A1—atherosclerosis	3.95e-05	0.000305	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—F2—atherosclerosis	3.9e-05	0.000302	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PLA2G1B—atherosclerosis	3.89e-05	0.000301	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—ALB—atherosclerosis	3.88e-05	0.0003	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCL4—atherosclerosis	3.88e-05	0.0003	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—NOS2—atherosclerosis	3.86e-05	0.000298	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	3.85e-05	0.000298	CbGpPWpGaD
Epirubicin—ABCC1—Disease—BGN—atherosclerosis	3.82e-05	0.000295	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PLA2G1B—atherosclerosis	3.81e-05	0.000295	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	3.77e-05	0.000292	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	3.76e-05	0.000291	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ALOX5—atherosclerosis	3.75e-05	0.00029	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—PIK3CG—atherosclerosis	3.74e-05	0.000289	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	3.74e-05	0.000289	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	3.73e-05	0.000289	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—IL6—atherosclerosis	3.73e-05	0.000289	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	3.73e-05	0.000288	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—NOS3—atherosclerosis	3.72e-05	0.000287	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—MAPK3—atherosclerosis	3.68e-05	0.000285	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ALOX5—atherosclerosis	3.68e-05	0.000285	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP27A1—atherosclerosis	3.65e-05	0.000282	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—APOA2—atherosclerosis	3.62e-05	0.00028	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	3.59e-05	0.000278	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	3.59e-05	0.000278	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—APOB—atherosclerosis	3.58e-05	0.000277	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	3.51e-05	0.000271	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—KNG1—atherosclerosis	3.47e-05	0.000268	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PLA2G2A—atherosclerosis	3.46e-05	0.000268	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—APOA2—atherosclerosis	3.46e-05	0.000268	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ALOX15—atherosclerosis	3.46e-05	0.000268	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ALOX5AP—atherosclerosis	3.46e-05	0.000268	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—UTS2—atherosclerosis	3.45e-05	0.000267	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—AGTR1—atherosclerosis	3.45e-05	0.000267	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—IGF1—atherosclerosis	3.42e-05	0.000265	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ABCG5—atherosclerosis	3.42e-05	0.000264	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	3.41e-05	0.000264	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	3.4e-05	0.000263	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PTGS2—atherosclerosis	3.4e-05	0.000263	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—NAMPT—atherosclerosis	3.37e-05	0.00026	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—LIPC—atherosclerosis	3.35e-05	0.000259	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CST3—atherosclerosis	3.33e-05	0.000257	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—APOC3—atherosclerosis	3.33e-05	0.000257	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CX3CR1—atherosclerosis	3.31e-05	0.000256	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CASR—atherosclerosis	3.31e-05	0.000256	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—LDLR—atherosclerosis	3.31e-05	0.000256	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—NAMPT—atherosclerosis	3.3e-05	0.000255	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—LPA—atherosclerosis	3.3e-05	0.000255	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—MAPK3—atherosclerosis	3.29e-05	0.000255	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	3.28e-05	0.000254	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—LIPC—atherosclerosis	3.28e-05	0.000254	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—APOC3—atherosclerosis	3.26e-05	0.000252	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—SERPINE1—atherosclerosis	3.25e-05	0.000251	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CX3CL1—atherosclerosis	3.25e-05	0.000251	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—ALB—atherosclerosis	3.24e-05	0.000251	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—LDLR—atherosclerosis	3.24e-05	0.000251	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CETP—atherosclerosis	3.23e-05	0.00025	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—BGN—atherosclerosis	3.2e-05	0.000247	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	3.17e-05	0.000245	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CETP—atherosclerosis	3.17e-05	0.000245	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—APOA5—atherosclerosis	3.16e-05	0.000245	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NAMPT—atherosclerosis	3.15e-05	0.000244	CbGpPWpGaD
Epirubicin—ABCC1—Disease—APOC3—atherosclerosis	3.11e-05	0.000241	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	3.11e-05	0.00024	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—NOS3—atherosclerosis	3.1e-05	0.00024	CbGpPWpGaD
Epirubicin—ABCC1—Disease—LDLR—atherosclerosis	3.09e-05	0.000239	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—SCARB1—atherosclerosis	3.09e-05	0.000239	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CNR2—atherosclerosis	3.08e-05	0.000238	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	3.07e-05	0.000238	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—MMP3—atherosclerosis	3.07e-05	0.000238	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PLA2G1B—atherosclerosis	3.05e-05	0.000236	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—SCARB1—atherosclerosis	3.03e-05	0.000235	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—PPARA—atherosclerosis	3.02e-05	0.000233	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	3.01e-05	0.000233	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HSPA1B—atherosclerosis	2.99e-05	0.000231	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.98e-05	0.000231	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.98e-05	0.00023	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.95e-05	0.000228	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ALOX5—atherosclerosis	2.94e-05	0.000228	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—EDN1—atherosclerosis	2.92e-05	0.000226	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—HMGCR—atherosclerosis	2.92e-05	0.000226	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CCL5—atherosclerosis	2.9e-05	0.000224	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NCF1—atherosclerosis	2.89e-05	0.000224	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—HMGCR—atherosclerosis	2.86e-05	0.000221	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.83e-05	0.000219	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	2.77e-05	0.000214	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PRKCG—atherosclerosis	2.76e-05	0.000213	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—VWF—atherosclerosis	2.74e-05	0.000212	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—APOC3—atherosclerosis	2.73e-05	0.000211	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CYBA—atherosclerosis	2.72e-05	0.00021	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.72e-05	0.00021	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—LDLR—atherosclerosis	2.71e-05	0.00021	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PARP1—atherosclerosis	2.66e-05	0.000206	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCL3—atherosclerosis	2.65e-05	0.000205	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—NAMPT—atherosclerosis	2.64e-05	0.000204	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.62e-05	0.000203	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—LIPC—atherosclerosis	2.62e-05	0.000203	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—APOC3—atherosclerosis	2.61e-05	0.000202	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ABCA1—atherosclerosis	2.6e-05	0.000201	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—LDLR—atherosclerosis	2.59e-05	0.0002	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.58e-05	0.0002	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—MAPK3—atherosclerosis	2.58e-05	0.000199	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ABCA1—atherosclerosis	2.55e-05	0.000197	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NCF1—atherosclerosis	2.54e-05	0.000196	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CETP—atherosclerosis	2.53e-05	0.000196	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—AGT—atherosclerosis	2.43e-05	0.000188	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SCARB1—atherosclerosis	2.42e-05	0.000187	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCR2—atherosclerosis	2.39e-05	0.000185	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—EDNRA—atherosclerosis	2.39e-05	0.000185	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CYBA—atherosclerosis	2.38e-05	0.000184	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.36e-05	0.000182	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GHRL—atherosclerosis	2.33e-05	0.00018	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PARP1—atherosclerosis	2.33e-05	0.00018	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PLAT—atherosclerosis	2.33e-05	0.00018	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—MAPK3—atherosclerosis	2.3e-05	0.000178	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—HMGCR—atherosclerosis	2.29e-05	0.000177	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—ALB—atherosclerosis	2.24e-05	0.000173	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—F2—atherosclerosis	2.24e-05	0.000173	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—VEGFA—atherosclerosis	2.23e-05	0.000173	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—HMOX1—atherosclerosis	2.23e-05	0.000173	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—HMOX1—atherosclerosis	2.19e-05	0.000169	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PIK3CG—atherosclerosis	2.14e-05	0.000166	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—APOB—atherosclerosis	2.14e-05	0.000165	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—MAPK3—atherosclerosis	2.11e-05	0.000164	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—APOB—atherosclerosis	2.1e-05	0.000162	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GSTM1—atherosclerosis	2.08e-05	0.000161	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.06e-05	0.00016	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TGFB1—atherosclerosis	2.05e-05	0.000159	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—KNG1—atherosclerosis	2.05e-05	0.000158	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—LPL—atherosclerosis	2.04e-05	0.000158	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GSTM1—atherosclerosis	2.04e-05	0.000158	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ABCA1—atherosclerosis	2.04e-05	0.000158	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AGTR1—atherosclerosis	2.04e-05	0.000157	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—LPL—atherosclerosis	2e-05	0.000155	CbGpPWpGaD
Epirubicin—ABCC1—Disease—APOB—atherosclerosis	2e-05	0.000155	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CCL2—atherosclerosis	2e-05	0.000154	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GPX1—atherosclerosis	1.99e-05	0.000154	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PLG—atherosclerosis	1.98e-05	0.000153	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GPX1—atherosclerosis	1.95e-05	0.000151	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CD36—atherosclerosis	1.94e-05	0.00015	CbGpPWpGaD
Epirubicin—ABCC1—Disease—LPL—atherosclerosis	1.91e-05	0.000148	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CD36—atherosclerosis	1.9e-05	0.000147	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SOCS3—atherosclerosis	1.88e-05	0.000145	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PRKCG—atherosclerosis	1.86e-05	0.000144	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—MTHFR—atherosclerosis	1.84e-05	0.000142	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MMP3—atherosclerosis	1.81e-05	0.00014	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IGF2—atherosclerosis	1.81e-05	0.00014	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PPARA—atherosclerosis	1.8e-05	0.00014	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—MTHFR—atherosclerosis	1.8e-05	0.000139	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PPARA—atherosclerosis	1.77e-05	0.000137	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—APOB—atherosclerosis	1.75e-05	0.000136	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—HMOX1—atherosclerosis	1.75e-05	0.000135	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—AGT—atherosclerosis	1.75e-05	0.000135	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—EDN1—atherosclerosis	1.73e-05	0.000133	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MTHFR—atherosclerosis	1.72e-05	0.000133	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—AGT—atherosclerosis	1.71e-05	0.000133	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCL5—atherosclerosis	1.71e-05	0.000132	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—APOE—atherosclerosis	1.71e-05	0.000132	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—AKT1—atherosclerosis	1.71e-05	0.000132	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CAV1—atherosclerosis	1.7e-05	0.000131	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—APOA1—atherosclerosis	1.69e-05	0.000131	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—APOE—atherosclerosis	1.68e-05	0.00013	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—APOB—atherosclerosis	1.68e-05	0.00013	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—LPL—atherosclerosis	1.67e-05	0.00013	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PDGFB—atherosclerosis	1.67e-05	0.00013	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CAV1—atherosclerosis	1.66e-05	0.000129	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—APOA1—atherosclerosis	1.66e-05	0.000128	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GSTM1—atherosclerosis	1.63e-05	0.000126	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PRKCG—atherosclerosis	1.63e-05	0.000126	CbGpPWpGaD
Epirubicin—ABCC1—Disease—APOE—atherosclerosis	1.6e-05	0.000124	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—LPL—atherosclerosis	1.6e-05	0.000124	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CAV1—atherosclerosis	1.59e-05	0.000123	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SPP1—atherosclerosis	1.59e-05	0.000123	CbGpPWpGaD
Epirubicin—ABCC1—Disease—APOA1—atherosclerosis	1.58e-05	0.000122	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CXCL8—atherosclerosis	1.58e-05	0.000122	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GPX1—atherosclerosis	1.56e-05	0.000121	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PIK3CG—atherosclerosis	1.54e-05	0.000119	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CD36—atherosclerosis	1.52e-05	0.000118	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PIK3CG—atherosclerosis	1.52e-05	0.000117	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOS2—atherosclerosis	1.49e-05	0.000115	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PPARG—atherosclerosis	1.49e-05	0.000115	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PDGFB—atherosclerosis	1.47e-05	0.000114	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—INS—atherosclerosis	1.46e-05	0.000113	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PPARG—atherosclerosis	1.46e-05	0.000113	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—MTHFR—atherosclerosis	1.44e-05	0.000111	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—INS—atherosclerosis	1.43e-05	0.000111	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AGT—atherosclerosis	1.43e-05	0.000111	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—AKT1—atherosclerosis	1.43e-05	0.00011	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PPARA—atherosclerosis	1.41e-05	0.000109	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—APOE—atherosclerosis	1.4e-05	0.000109	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—LEP—atherosclerosis	1.4e-05	0.000109	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CAV1—atherosclerosis	1.39e-05	0.000108	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—APOA1—atherosclerosis	1.39e-05	0.000107	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—AGT—atherosclerosis	1.37e-05	0.000106	CbGpPWpGaD
Epirubicin—ABCC1—Disease—INS—atherosclerosis	1.37e-05	0.000106	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—APOE—atherosclerosis	1.34e-05	0.000104	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ALB—atherosclerosis	1.34e-05	0.000104	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ESR1—atherosclerosis	1.34e-05	0.000104	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CAV1—atherosclerosis	1.33e-05	0.000103	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—APOA1—atherosclerosis	1.33e-05	0.000103	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—F2—atherosclerosis	1.32e-05	0.000102	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ALB—atherosclerosis	1.31e-05	0.000102	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—NOS3—atherosclerosis	1.28e-05	9.92e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PIK3CG—atherosclerosis	1.27e-05	9.8e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—NOS3—atherosclerosis	1.26e-05	9.73e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SERPINE1—atherosclerosis	1.26e-05	9.72e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—MAPK3—atherosclerosis	1.21e-05	9.38e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PIK3CG—atherosclerosis	1.21e-05	9.36e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOS3—atherosclerosis	1.2e-05	9.28e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—INS—atherosclerosis	1.2e-05	9.27e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCL2—atherosclerosis	1.18e-05	9.13e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PTGS2—atherosclerosis	1.17e-05	9.07e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PPARG—atherosclerosis	1.17e-05	9.04e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IGF1—atherosclerosis	1.16e-05	8.97e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PTGS2—atherosclerosis	1.15e-05	8.9e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—INS—atherosclerosis	1.15e-05	8.86e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SERPINE1—atherosclerosis	1.1e-05	8.52e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PTGS2—atherosclerosis	1.1e-05	8.49e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NOS3—atherosclerosis	1.05e-05	8.13e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ALB—atherosclerosis	1.05e-05	8.13e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—NOS3—atherosclerosis	1e-05	7.77e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CXCL8—atherosclerosis	9.33e-06	7.21e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PTGS2—atherosclerosis	9.19e-06	7.11e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL6—atherosclerosis	8.87e-06	6.86e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—STAT3—atherosclerosis	8.56e-06	6.62e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MMP9—atherosclerosis	8.44e-06	6.53e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NFKB1—atherosclerosis	8.35e-06	6.46e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MAPK8—atherosclerosis	8.21e-06	6.35e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—AKT1—atherosclerosis	8.18e-06	6.33e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MAPK3—atherosclerosis	8.18e-06	6.32e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TGFB1—atherosclerosis	7.93e-06	6.14e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—VEGFA—atherosclerosis	7.58e-06	5.86e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—STAT3—atherosclerosis	7.5e-06	5.8e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MAPK3—atherosclerosis	7.17e-06	5.54e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TGFB1—atherosclerosis	6.95e-06	5.38e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IL6—atherosclerosis	5.98e-06	4.62e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—AKT1—atherosclerosis	5.9e-06	4.56e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—AKT1—atherosclerosis	5.78e-06	4.47e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—AKT1—atherosclerosis	5.52e-06	4.27e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL6—atherosclerosis	5.24e-06	4.05e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AKT1—atherosclerosis	4.83e-06	3.74e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—AKT1—atherosclerosis	4.62e-06	3.57e-05	CbGpPWpGaD
